CN103446358A - Tibetan medicine Iris uniflora pall antioxidant extract and preparation method and application thereof - Google Patents
Tibetan medicine Iris uniflora pall antioxidant extract and preparation method and application thereof Download PDFInfo
- Publication number
- CN103446358A CN103446358A CN2013104154080A CN201310415408A CN103446358A CN 103446358 A CN103446358 A CN 103446358A CN 2013104154080 A CN2013104154080 A CN 2013104154080A CN 201310415408 A CN201310415408 A CN 201310415408A CN 103446358 A CN103446358 A CN 103446358A
- Authority
- CN
- China
- Prior art keywords
- extract
- iris
- rock
- extracts
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 77
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 238000000605 extraction Methods 0.000 title claims description 29
- 239000003963 antioxidant agent Substances 0.000 title abstract description 11
- 241001517065 Iris uniflora Species 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003208 petroleum Substances 0.000 claims abstract description 17
- 239000002026 chloroform extract Substances 0.000 claims abstract description 11
- 239000012259 ether extract Substances 0.000 claims abstract description 11
- 239000002024 ethyl acetate extract Substances 0.000 claims abstract description 10
- 239000002021 butanolic extract Substances 0.000 claims abstract description 9
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000011435 rock Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- -1 buccal preparation Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims description 2
- 239000007939 sustained release tablet Substances 0.000 claims description 2
- 239000012730 sustained-release form Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000012675 alcoholic extract Substances 0.000 claims 1
- 238000002137 ultrasound extraction Methods 0.000 claims 1
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 6
- 238000000338 in vitro Methods 0.000 abstract description 5
- 150000002632 lipids Chemical class 0.000 abstract description 2
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 abstract 2
- 150000003254 radicals Chemical class 0.000 description 18
- 230000000694 effects Effects 0.000 description 11
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241001113425 Iridaceae Species 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 244000284012 Vetiveria zizanioides Species 0.000 description 2
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- PSFDQSOCUJVVGF-UHFFFAOYSA-N harman Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C PSFDQSOCUJVVGF-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000596154 Belamcanda Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000018086 Iris halophila Species 0.000 description 1
- 244000071493 Iris tectorum Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及含有抗氧化作用的岩生鸢尾有效提取物及其制备方法,所述有效提取物选自从岩生鸢尾醇提物中萃取得到的石油醚提取物、氯仿提取物、乙酸乙酯提取物、正丁醇提取物和水提取物之一或其其组合,研究证明,其中石油醚提取物、氯仿提取物和正丁醇提取物具有明显的体外清除羟基自由基能力;乙酸乙酯提取物和水提取物具有明显体外清除DPPH(二苯代苦味肼)脂性自由基的能力,因此,所述有效提取物可用于制备抗氧化药物和化妆品。The present invention relates to an effective extract of Iris chrysalis containing anti-oxidation and a preparation method thereof. The effective extract is selected from petroleum ether extract, chloroform extract, ethyl acetate extract, ortho One of butanol extract and water extract or its combination, studies have shown that petroleum ether extract, chloroform extract and n-butanol extract have obvious ability to scavenge hydroxyl radicals in vitro; ethyl acetate extract and water extract The extract has obvious ability to scavenge DPPH (diphenylpicrylhydrazine) lipid free radicals in vitro, therefore, the effective extract can be used to prepare antioxidant drugs and cosmetics.
Description
技术领域 technical field
本发明涉及一种藏药岩生鸢尾抗氧化提取物及其制备方法;本发明进一步涉及所述提取物的药物组合物;本发明还涉及所述提取物在抗氧化药物或化妆品中的应用;属于中药领域。 The present invention relates to a kind of anti-oxidation extract of Tibetan medicine Iris chrysalis and its preparation method; the present invention further relates to the pharmaceutical composition of the extract; the present invention also relates to the application of the extract in antioxidant drugs or cosmetics; The field of traditional Chinese medicine.
背景技术 Background technique
1956年,英国人Harman提出“自由基学说”,该学说认为自由基攻击生命大分子造成组织损伤,是引起机体衰老的根本原因,也是诱发肿瘤恶性疾病的重大原因。随着人们对自由基研究的深入,这一学说也为越来越多的人接受。自由基是指“任何包含一个未成对电子的原子或原子团”,对人体健康影响极大。在生理情况下,氧处于较低水平,其产生和清除处于动态平衡,但在某些病理情况下,自由基过剩,导致机体损伤。自由基除本身对生物大分子(蛋白质、DNA)有损伤作用外,还会造成多不饱和脂肪酸的脂质过氧化( LPO) ,而LPO 反应的终产物是丙二醛(MDA),从而使蛋白质、核酸、脑磷脂发生交联并丧失其活性。大量研究表明,与老化相关的疾病和基因的突变,如癌症、心血管疾病、风湿性关节炎、糖尿病、神经性疾病、衰老等都同自由基导致的损伤相关,清除了体内多余的自由基就能预防衰老和疾病。因此寻求利用人体易于吸收的、能清除体内过量自由基的外源抗氧化剂成为一个新的研究热点。然而,随着合成抗氧化剂日益突出的潜在毒性和致癌作用被人们排斥,从植物中寻找天然、高效、低毒的抗氧化剂就成为了目前抗氧化剂发展的一个必然趋势,同时也为现代医学和保健行业的指明了方向。 In 1956, the British Harman proposed the "free radical theory", which believed that free radicals attack life macromolecules and cause tissue damage, which is the root cause of body aging and a major cause of tumor malignant diseases. With the in-depth study of free radicals, this theory has been accepted by more and more people. Free radicals refer to "any atom or atomic group containing an unpaired electron", which has a great impact on human health. Under physiological conditions, oxygen is at a low level, and its production and removal are in a dynamic balance, but in some pathological conditions, free radicals are excessive, causing damage to the body. In addition to its own damage to biological macromolecules (proteins, DNA), free radicals can also cause lipid peroxidation (LPO) of polyunsaturated fatty acids, and the end product of LPO reaction is malondialdehyde (MDA), so that Proteins, nucleic acids, cephalins are cross-linked and lose their activity. A large number of studies have shown that diseases and gene mutations related to aging, such as cancer, cardiovascular disease, rheumatoid arthritis, diabetes, neurological diseases, aging, etc., are all related to the damage caused by free radicals, eliminating excess free radicals in the body Aging and disease can be prevented. Therefore, seeking to utilize exogenous antioxidants that are easily absorbed by the human body and can remove excess free radicals in the body has become a new research hotspot. However, as the increasingly prominent potential toxicity and carcinogenic effects of synthetic antioxidants are rejected by people, it has become an inevitable trend in the development of antioxidants to find natural, high-efficiency, and low-toxicity antioxidants from plants. The healthcare industry has pointed the way.
鸢尾属(Iirs)是鸢尾科的一个大属,全世界约有300余种植物,该属植物被广泛作为传统的民间药物,用来治疗多种疾病,例如,癌症、炎症、细菌和病毒感染。据报道,已从鸢尾属植物中分离得到具有抗肿瘤、抗氧化、抗结核、坑疟原虫等活性的化合物。其中鸢尾(Iris tectorum Maxim)、喜碱鸢尾(Iris halophila Pall)、香根鸢尾(Irish pallida)、射干(Belamcanda chinensis (L.) DC)均有抗氧化活性报道,特别是香根鸢尾根部提取物被用于某些化妆品中。岩生鸢尾(Iris uniflora Pall),藏名则合纪泽玛,是鸢尾科鸢尾属多年生草本植物,产于西藏、青海、内蒙等地,常以种子入药,能杀虫,解毒,藏医中用于驱虫;外敷撒疮口,可去腐生肌,治烧伤;其花能明目,根可治雀斑和癣,全草烧灰存性可乌发。其化学成分和活性并无报道,更未见到岩生鸢尾及其有效部位抗氧化作用研究与应用方面的报道。我们对其总提物及不同溶剂极性部位进行了抗氧化活性的初步研究,活性实验表明:其总提物和某些极性部位具有良好抗氧化活性。 The genus Iirs (Iirs) is a large genus of Iridaceae. There are more than 300 species of plants in the world. The plants of this genus are widely used as traditional folk medicines to treat various diseases, such as cancer, inflammation, bacterial and viral infections. . According to reports, compounds with anti-tumor, anti-oxidation, anti-tuberculosis, and Plasmodium crater activities have been isolated from plants of the genus Iris. Among them, Iris tectorum Maxim, Iris halophila Pall, Iris vetiver ( Irish pallida ), and Shegan ( Belamcanda chinensis (L.) DC) all have antioxidant activity reports, especially the root extract of Iris vetiver Used in some cosmetics. Iris uniflora Pall (Iris uniflora Pall), whose Tibetan name is Heji Zema, is a perennial herb of the family Iridaceae. It is produced in Tibet, Qinghai, Inner Mongolia and other places. Its seeds are often used as medicine, which can kill insects and detoxify. It is used in Tibetan medicine. Deworming; external application on sores can remove putrefaction and regenerate muscle, and treat burns; its flowers can improve eyesight, its roots can cure freckles and ringworm, and the whole plant can be burned to black hair. There is no report on its chemical composition and activity, and there is no report on the research and application of Iris lithophylla and its effective parts on the antioxidant effect. We have conducted preliminary research on the antioxidant activity of its total extract and polar parts of different solvents. The activity experiments show that its total extract and some polar parts have good antioxidant activity.
发明内容 Contents of the invention
本发明的目的之一是,提供一种岩生鸢尾的抗氧化提取物及其制备方法。本发明的目的之二是,提供一种以所述提取物为有效成分的药物组合物。本发明的目的之三是,提供所述提取物在制备抗氧化及其相关药物和化妆品中的应用。 One of the objectives of the present invention is to provide an antioxidant extract of Iris rock and its preparation method. The second object of the present invention is to provide a pharmaceutical composition containing the extract as an active ingredient. The third object of the present invention is to provide the application of the extract in the preparation of anti-oxidation and related medicines and cosmetics.
本发明比较了不同溶剂的萃取物的抗氧化活性,确定了具有抗氧化作用的提取物及其制备方法。 The invention compares the antioxidant activity of the extracts of different solvents, and determines the extract with antioxidant effect and the preparation method thereof.
本发明所述岩生鸢尾提取物选自从岩生鸢尾醇提物中萃取得到的石油醚提取物(YS-1)、氯仿提取物(YS-2)、乙酸乙酯提取物(YS-3)、正丁醇提取物(YS-4)和水提取物(YS-5)之一或其组合; 优选从岩生鸢尾醇提物中萃取得到的石油醚提取物(YS-1)、氯仿提取物(YS-2)或其组合;或者优选从岩生鸢尾醇提物中萃取得到的乙酸乙酯提取物、水提取物或其组合;或者优选从岩生鸢尾醇提物中萃取得到的正丁醇提取物。 The Iris rock extract in the present invention is selected from petroleum ether extract (YS-1), chloroform extract (YS-2), ethyl acetate extract (YS-3), and normal One or a combination of butanol extract (YS-4) and water extract (YS-5); preferably petroleum ether extract (YS-1), chloroform extract (YS -2) or a combination thereof; or preferably an ethyl acetate extract, a water extract, or a combination thereof extracted from the ethanol extract of Iris chrysalis; or preferably a n-butanol extract extracted from the ethanol extract of Iris chrysalis.
本发明的提取物可以经过提取、浓缩、系列萃取得到,其制备方法包括以下步骤: The extract of the present invention can be obtained through extraction, concentration and series extraction, and its preparation method comprises the following steps:
(1)取岩生鸢尾全草或地下部分粗粉, 用乙醇浸泡,超声波助溶提取,过滤,滤渣重复上述提取,过滤,合并提取液; (1) Take the whole plant or the underground part of Iris chrysalis, soak it in ethanol, extract it with ultrasonic solution, filter it, and repeat the above extraction with the filter residue, filter it, and combine the extracts;
(2)将提取液减压浓缩得到浓缩液,再将浓缩液与水混合,得到稀释后的浓缩液; (2) concentrating the extract under reduced pressure to obtain a concentrated solution, and then mixing the concentrated solution with water to obtain a diluted concentrated solution;
(3)用不同极性的溶剂石油醚、氯仿、乙酸乙酯和正丁醇梯度萃取,每种溶剂重复萃取,合并相同有机相,减压浓缩得到各溶剂的提取物。 (3) Gradient extraction with solvents of different polarities such as petroleum ether, chloroform, ethyl acetate and n-butanol, each solvent was repeatedly extracted, the same organic phases were combined, and concentrated under reduced pressure to obtain the extracts of each solvent.
所述方法优选包括以下步骤: (1)取岩生鸢尾全草或地下部分粗粉, 用30倍质量的乙醇浸泡24 h,超声波助溶提取1 h,过滤,滤渣重复上述提取过程2次,过滤,合并三次提取液,其中所用乙醇优选60-90%乙醇;(2)将提取液减压浓缩至相对密度为1.10-1.24 mg/mL(50℃),得到浓缩液,再将浓缩液与水按体积比1:1混合,得到稀释后的浓缩液;(3)用与稀释后浓缩液等体积的不同极性溶剂石油醚、氯仿、乙酸乙酯、正丁醇梯度萃取,每种溶剂分别重复萃取2次萃取2次,合并相同有机相,减压浓缩得到各溶剂的提取物。 The method preferably includes the following steps: (1) Take the whole grass of Iris chrysalis or the coarse powder of the underground part, soak it with 30 times the mass of ethanol for 24 h, extract it with ultrasonic solution for 1 h, filter, repeat the above extraction process twice for the filter residue, and filter , combined three extracts, wherein the ethanol used is preferably 60-90% ethanol; (2) Concentrate the extract under reduced pressure to a relative density of 1.10-1.24 mg/mL (50°C) to obtain a concentrate, and then mix the concentrate with water Mix at a volume ratio of 1:1 to obtain the diluted concentrated solution; (3) gradient extraction with different polar solvents, petroleum ether, chloroform, ethyl acetate, and n-butanol, which is equal to the volume of the diluted concentrated solution, each solvent is respectively Repeat the extraction twice and extract twice, combine the same organic phases, and concentrate under reduced pressure to obtain the extracts of each solvent.
本发明还提供以所述方法制备的各溶剂提取物的药物组合物。所述药物组合物是以本发明的提取物为有效成分,与药学上可接受的载体所组成,并以合适的药用制剂形式存在,这些制剂可以是片剂(优选糖衣片剂、薄膜衣片剂、肠溶衣片剂和缓释片剂)、胶囊剂(优选硬胶囊剂、软胶囊剂或缓释胶囊剂)、口服液、合剂、口含剂、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、溶液剂、注射剂、粉针剂、冻干粉针剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴丸、滴丸剂、贴剂等。 The present invention also provides pharmaceutical compositions of each solvent extract prepared by the method. The pharmaceutical composition takes the extract of the present invention as an active ingredient, is composed of a pharmaceutically acceptable carrier, and exists in the form of a suitable pharmaceutical preparation. These preparations can be tablets (preferably sugar-coated tablets, film-coated tablets, etc.) tablets, enteric-coated tablets and sustained-release tablets), capsules (preferably hard capsules, soft capsules or sustained-release capsules), oral liquids, mixtures, buccal preparations, granules, granules, pills, powders , ointment, pill, suspension, solution, injection, powder injection, freeze-dried powder injection, suppository, ointment, plaster, cream, spray, dripping pill, dripping pill, patch, etc.
本发明进一步提供了各种提取物在制备治疗和或预防氧化药物和化妆品中的应用。为此进行的抗氧化相关实验以清除DPPH自由基、羟基自由基为活性指标。实验结果表明,乙酸乙酯提取物和水提取物具有明显体外清除DPPH脂性自由基的能力;石油醚提取物和氯仿提取物具有较好清除羟基自由基,具有抗氧化作用,可用于制备抗氧化药物和化妆品。 The present invention further provides the application of various extracts in the preparation of medicines and cosmetics for treating and preventing oxidation. The anti-oxidation-related experiments carried out for this purpose used scavenging DPPH free radicals and hydroxyl free radicals as activity indicators. The experimental results show that the ethyl acetate extract and water extract have obvious ability to scavenge DPPH lipid free radicals in vitro; the petroleum ether extract and chloroform extract have better scavenging hydroxyl free radicals, have anti-oxidation effect, and can be used to prepare antioxidant Drugs and Cosmetics.
具体实施方案:Specific implementation plan:
实施例1:Example 1:
各提取物的制备方法: The preparation method of each extract:
1)总提物提取 1) Total extract extraction
取岩生鸢尾全草粗粉20 g, 用600 ml 90%乙醇浸泡24 h,超声波助溶提取1 h,过滤,滤渣重复上述提取过程2次,过滤,合并三次提取液。 Take 20 g of the whole Iris rock powder, soak it in 600 ml of 90% ethanol for 24 h, extract it with ultrasonic solution for 1 h, filter, repeat the above extraction process twice for the filter residue, filter, and combine the three extracts.
2)浓缩 2) concentrated
将提取液减压回收乙醇得浓缩液(相对密度为1.12g/mL, 50℃),再将浓缩液与水按体积比1:1混合,得到稀释后的浓缩液( 100 ml)。 Recover ethanol from the extract under reduced pressure to obtain a concentrated solution (relative density 1.12g/mL, 50°C), and then mix the concentrated solution with water at a volume ratio of 1:1 to obtain a diluted concentrated solution (100 ml).
3)梯度萃取 3) Gradient extraction
依次用石油醚(100 ml/次×3次)、氯仿(100 ml/次×3次)、乙酸乙酯(100 ml/次×3次)、正丁醇(100 ml/次×3次)萃取稀释后的浓缩液,合并相同有机相,减压浓缩,得到石油醚提取物(YS-1, 0.35 g, 提取率: 1.75%)、氯仿提取物(YS-2,0.62 g, 提取率: 3.1%)、乙酸乙酯提取物(YS-3, 0.23 g, 提取率:1.15%)、正丁醇提取物(YS-4,0.14 g, 提取率:0.7%)和水提取物(YS-5,0.67 g, 提取率:3.35%)。 Sequentially use petroleum ether (100 ml/time x 3 times), chloroform (100 ml/time x 3 times), ethyl acetate (100 ml/time x 3 times), n-butanol (100 ml/time x 3 times) Extract the diluted concentrated solution, combine the same organic phases, and concentrate under reduced pressure to obtain petroleum ether extract (YS-1, 0.35 g, extraction rate: 1.75%), chloroform extract (YS-2, 0.62 g, extraction rate: 3.1%), ethyl acetate extract (YS-3, 0.23 g, extraction rate: 1.15%), n-butanol extract (YS-4, 0.14 g, extraction rate: 0.7%) and water extract (YS- 5, 0.67 g, extraction rate: 3.35%).
实施例2: Embodiment 2 :
各提取物的制备方法: The preparation method of each extract:
1)总提物提取 1) Total extract extraction
取岩生鸢尾全草粗粉20 g, 用600 ml 80%乙醇浸泡24 h,超声波助溶提取1 h,过滤,滤渣重复上述提取过程2次,过滤,合并三次提取液。 Take 20 g of the whole Iris rock powder, soak it in 600 ml of 80% ethanol for 24 h, extract it with ultrasonic solution for 1 h, filter, repeat the above extraction process twice for the filter residue, filter, and combine the three extracts.
2)浓缩 2) concentrated
将提取液减压回收乙醇得浓缩液(相对密度为1.16g/ml, 50℃),再将浓缩液与水按体积比1:1混合,得到稀释后的浓缩液( 80 ml)。 Recover ethanol from the extract under reduced pressure to obtain a concentrated solution (relative density 1.16g/ml, 50°C), and then mix the concentrated solution with water at a volume ratio of 1:1 to obtain a diluted concentrated solution (80 ml).
3)梯度萃取 3) Gradient extraction
依次用石油醚(80 ml/次×3次)、氯仿(80 ml/次×3次)、乙酸乙酯(80 ml/次×3次)、正丁醇(80 ml/次×3次)萃取稀释后的浓缩液,合并相同有机相,减压浓缩,得到石油醚提取物(YS-1, 0.21 g, 提取率: 1.05%)、氯仿提取物(YS-2,0.95 g, 提取率: 4.75%)、乙酸乙酯提取物(YS-3, 0.33 g, 提取率:1.65%)、正丁醇提取物(YS-4,0.14 g, 提取率:2.8%)和水提取物(YS-5,0.29 g, 提取率:1.45%)。 Sequentially use petroleum ether (80 ml/time x 3 times), chloroform (80 ml/time x 3 times), ethyl acetate (80 ml/time x 3 times), n-butanol (80 ml/time x 3 times) Extract the diluted concentrated solution, combine the same organic phases, and concentrate under reduced pressure to obtain petroleum ether extract (YS-1, 0.21 g, extraction rate: 1.05%), chloroform extract (YS-2, 0.95 g, extraction rate: 4.75%), ethyl acetate extract (YS-3, 0.33 g, extraction rate: 1.65%), n-butanol extract (YS-4, 0.14 g, extraction rate: 2.8%) and water extract (YS- 5, 0.29 g, extraction rate: 1.45%).
实施例3: Embodiment 3 :
清除DPPH自由基活性实验: Scavenging DPPH free radical activity experiment:
采用实施例1中所制备各极性部位进行活性实验。 Activity experiments were carried out using the polar sites prepared in Example 1.
抗氧化活性以清除DPPH自由基能力大小表示。根据预实验确定的实验条件,测定岩生鸢尾不同样品清除脂性自由基DPPH的活性。取不同浓度样品溶液2.0 mL,加入2.0 mL 1.52×10-4 mmol/L的DPPH无水乙醇溶液充分混匀,室温避光静置30 min 后,以溶剂为空白对照,517 nm处测吸光度A1;以同体积溶剂代替样品溶液做阴性对照,测定吸光度A2;以同体积无水乙醇代替DPPH溶液做空白组,测定吸光度A3。以VC为对照,每组做3个重复,求其平均值。按下式计算清除率: The antioxidant activity is expressed by the ability to scavenge DPPH free radicals. According to the experimental conditions determined in the pre-experiment, the activity of scavenging lipid free radical DPPH of different samples of Iris petus was determined. Take 2.0 mL of sample solutions with different concentrations, add 2.0 mL of 1.52×10 -4 mmol/L DPPH absolute ethanol solution and mix well, and after standing in the dark at room temperature for 30 min, use the solvent as a blank control, and measure the absorbance A at 517 nm 1 ; Use the same volume of solvent instead of sample solution as a negative control to measure absorbance A 2 ; use the same volume of absolute ethanol instead of DPPH solution as a blank group to measure absorbance A 3 . With VC as the control, each group was repeated three times, and the average value was calculated. Calculate the clearance rate according to the following formula:
样品对DPPH·的清除率(%)=[1-(A1-A3)/A2] ×100% Clearance rate of sample to DPPH·(%)=[1-(A 1 -A 3 )/A 2 ]×100%
实施例4: Embodiment 4 :
清除羟基自由基活性试验: Hydroxyl free radical scavenging activity test:
采用实施例1中所制备各极性部位进行活性实验。 Activity experiments were carried out using the polar sites prepared in Example 1.
抗氧化活性以清除羟基自由基能力大小表示。根据预实验确定的实验条件,测定岩生鸢尾不同样品清除羟基自由基的活性。将1.5 mL 1.8 mol/L 水杨酸溶液与2.0 mL 1.8 mol/L FeSO4 溶液于试管中混匀后,加入1 mL 不同浓度样品溶液,然后加入0.1 mL 0.03% H2O2,摇匀,于37 ℃保温30 min,510 nm 处测得样品组吸光度Ai;同时将样品组中H2O2换成0.1 mL蒸馏水,测得样品参照组吸光度Aj;将样品组中样品换成1.0 mL溶剂,测得空白组吸光度A0。以VC为对照,每组做3个重复,求其平均值。按下式计算清除率: Antioxidant activity is expressed by the ability to scavenge hydroxyl radicals. According to the experimental conditions determined in the pre-experiment, the activity of scavenging hydroxyl radicals of different samples of Iris lithosum was determined. Mix 1.5 mL of 1.8 mol/L salicylic acid solution and 2.0 mL of 1.8 mol/L FeSO 4 solution in the test tube, add 1 mL of sample solutions of different concentrations, then add 0.1 mL of 0.03% H 2 O 2 , shake well, Incubate at 37 ℃ for 30 min, measure the absorbance A i of the sample group at 510 nm; at the same time replace the H 2 O 2 in the sample group with 0.1 mL distilled water, measure the absorbance A j of the sample reference group; replace the sample in the sample group with 1.0 mL solvent, measure the absorbance A 0 of the blank group. With VC as the control, each group was repeated three times, and the average value was calculated. Calculate the clearance rate according to the following formula:
·OH清除率(%) = [A0-(Ai-Aj)] /A0×100% OH scavenging rate (%) = [A 0 -(A i -A j )] /A 0 ×100%
表1 岩生鸢尾各部位体外清除DPPH自由基活性实验 Table 1 The in vitro scavenging activity of DPPH free radicals in various parts of Iris lithophylla
注:IC50±s,n=3 Note: IC 50 ±s, n=3
表2 岩生鸢尾各部位体外清除羟基自由基活性实验 Table 2 Hydroxyl free radical scavenging activity test in vitro of various parts of Iris rockus
结果表明,采用本发明工艺制备得到的石油醚提取物(YS-1)、氯仿提取物(YS-2)、乙酸乙酯提取物(YS-3)、正丁醇提取物(YS-4)和水提取物(YS-5)具有良好抗氧化活性,其中石油醚提取物、氯仿提取物具有良好清除羟基自由基能力,抗氧化力分别约为VC的5/6和3/4; 乙酸乙酯提取物和水提取物具有良好清除DPPH自由基能力,抗氧化力分别为VC的1/7和1/11;而正丁醇部位清除羟基自由基能力在60-1250 μg/mL范围内均维持在50%左右,在浓度低于250 μg/mL时均强于VC。 The results show that the petroleum ether extract (YS-1), chloroform extract (YS-2), ethyl acetate extract (YS-3), and n-butanol extract (YS-4) prepared by the process of the present invention and water extract (YS-5) have good antioxidant activity, among which petroleum ether extract and chloroform extract have good ability to scavenge hydroxyl radicals, and their antioxidant capacity is about 5/6 and 3/4 of VC respectively; ethyl acetate Ester extract and water extract have good ability to scavenge DPPH free radicals, and the antioxidant power is 1/7 and 1/11 of VC respectively; while the ability of n-butanol to scavenge hydroxyl free radicals is in the range of 60-1250 μg/mL. It is maintained at about 50%, and it is stronger than VC when the concentration is lower than 250 μg/mL.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310415408.0A CN103446358B (en) | 2013-09-13 | 2013-09-13 | Tibetan medicine Piper pulicatulum C. D C. Rhizoma Iridis Tectori antioxidant extract and its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310415408.0A CN103446358B (en) | 2013-09-13 | 2013-09-13 | Tibetan medicine Piper pulicatulum C. D C. Rhizoma Iridis Tectori antioxidant extract and its production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103446358A true CN103446358A (en) | 2013-12-18 |
CN103446358B CN103446358B (en) | 2016-03-30 |
Family
ID=49729471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310415408.0A Expired - Fee Related CN103446358B (en) | 2013-09-13 | 2013-09-13 | Tibetan medicine Piper pulicatulum C. D C. Rhizoma Iridis Tectori antioxidant extract and its production and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103446358B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737369A (en) * | 2017-11-29 | 2018-02-27 | 桂林华诺威生物科技有限公司 | Collagen Skin diaphragm |
CN113651687A (en) * | 2021-09-26 | 2021-11-16 | 右江民族医学院 | Method for extracting antioxidant active substance from tsaoko amomum fruit |
-
2013
- 2013-09-13 CN CN201310415408.0A patent/CN103446358B/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
李小飞: "喜碱鸢尾根醇提取物抗氧化活性的研究", 《食品工业科技》, vol. 28, no. 11, 30 November 2007 (2007-11-30) * |
秦民坚等: "鸢尾科药用根茎类16种植物的异黄酮含量测定", 《植物资源与环境学报》, vol. 5, no. 4, 31 December 1996 (1996-12-31), pages 55 - 56 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737369A (en) * | 2017-11-29 | 2018-02-27 | 桂林华诺威生物科技有限公司 | Collagen Skin diaphragm |
CN113651687A (en) * | 2021-09-26 | 2021-11-16 | 右江民族医学院 | Method for extracting antioxidant active substance from tsaoko amomum fruit |
CN113651687B (en) * | 2021-09-26 | 2023-11-17 | 右江民族医学院 | A method of extracting antioxidant active substances from grass fruits |
Also Published As
Publication number | Publication date |
---|---|
CN103446358B (en) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI501772B (en) | Anti-arthritic activity | |
Chaudhri et al. | A Systematic Review of Piperine as a Bioavailability Enhancer. | |
CN102133247B (en) | Costustoot extractive with blood sugar reduction activity and application thereof | |
CN103446358B (en) | Tibetan medicine Piper pulicatulum C. D C. Rhizoma Iridis Tectori antioxidant extract and its production and use | |
CN101254217A (en) | A preparation method of the extract of the renewable part of the yew tree and the application of the extract in the preparation of oral anticancer drugs | |
CN104027367A (en) | Method for separating and purifying total polyphenol in redrlowered loropetalum by utilizing macroporous resin | |
CN104546952B (en) | A kind of selaginella doederlleini active component and its production and use | |
CN103936812B (en) | Lupinane type triterpene compound and pharmaceutical composition thereof are applied with it | |
CN103408528B (en) | Chroman compound, as well as preparation method and application thereof | |
CN105712844A (en) | Cadinane sesquiterpene Saliciforliusin A and preparation method and application thereof | |
CN102028780B (en) | Application of Rosa roxburghii Flavonoids in the Preparation of Ionizing Radiation Protection Drugs | |
CN116425651A (en) | Preparation method of N-alkylamide compound and application of N-alkylamide compound in anti-inflammatory drugs | |
CN100532349C (en) | Preparation of Phenolic Diphenylheptane Compounds and Its Antioxidant Application | |
CN103446198B (en) | Tibetan medicine Primula sikkimensis antioxidant extract and its production and use | |
CN102988525A (en) | Preparation method for total lignans in hawthorn seeds, and novel application | |
CN102775455A (en) | Dihydromyricetin medicine treating acute and chronic bronchitis and its preparation method | |
CN102276590B (en) | A kind of spin-labeled analogue of clematis extract and its preparation and application | |
CN112274542A (en) | Application of semiliquidambar cathayensis or extract thereof in preparation of anti-depression drugs | |
CN103450142B (en) | Chroman compound as well as extracting method and application thereof | |
CN106421455B (en) | Sweet sorghumus extract and preparation method and application thereof | |
CN105055479B (en) | Hainan eye tree lotus water extract anti-inflammatory active ingredient and application | |
CN103083376B (en) | Can be used for the Rhizoma Ligustici extract for the treatment of rhinitis | |
CN106491688A (en) | A kind of active site of radish and application thereof | |
CN107625774A (en) | Application and its extracting method of the cycloartenol in antineoplastic in Job's tears cauline leaf | |
CN101983633A (en) | New application of polysaccharides from fructus rosae roxburghii for protection against ionizing radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160330 Termination date: 20160913 |